2-chloro-3,3,3-trifluoroprop-1-ene Cas:2730-62-3

We are 2-chloro-3,3,3-trifluoroprop-1-ene CAS:2730-62-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


2-chloro-3,3,3-trifluoroprop-1-ene

Synonyms:
PC0682
2-Chloro-3,3,3-trifluoropropene
2-chloro-3,3,3-trifluoro-1-propene
HCFC-1233xf
HCFO-1233xf
 
Molecular Formula: C3H2ClF3
Molecular weight:130.49600
 
Density: 1.295 g/cm3
Boiling point: 27.7ºC at 760 mmHg

 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.



Market News: Grégoire then joined telecoms service provider Cirpack, following its acquisition of Andrexen, as Chief Marketing and Product Officer. He most recently held the position of Chief Strategy Officer at Experty.io, a blockchain-based knowledge sharing platform.N’-(8-chloro-11H-dibenzo[b,f][1,4]oxazepine-10-carbonyl)-succinohydrazidic acid manufacturer.Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. oct-6-yn-4-ol supplier CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. 5-methyl-3-(5-methylpyridin-2-yl)isoxazolo[5,4-d][1,2,3]triazin-4(3H)-one producer

Related Products
Product Name
trans-Hexahydroisobenzofuran-1,3-dione View Details
4-(3-bromophenyl)-6-phenyldibenzo[b,d]furan View Details
Tert-Butyl 3-aminopyrrolidine-1-carboxylate Cas:186550-13-0 View Details
3-Dimethylamino-1-propanol manufacturer Corticotropin manufacturer Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate manufacturer Calcium Bis(2-hydroxy-4-(methylthio)butyrate) Cas:4857-44-7 manufacturer hbtu Cas:94790-37-1 manufacturer